Dr. Glenn J. Lesser

Claim this profile

Wake Forest University Health Sciences

Studies Brain Tumor

Studies Glioblastoma

15 reported clinical trials

28 drugs studied

Area of expertise

1Brain Tumor

Glenn J. Lesser has run 9 trials for Brain Tumor. Some of their research focus areas include:

SMO positive

PTCH1 positive

MET positive

2Glioblastoma

Glenn J. Lesser has run 8 trials for Glioblastoma. Some of their research focus areas include:

MET positive

MET negative

VEGF

Affiliated Hospitals

Wake Forest University Health Sciences

Wake Forest University Comprehensive Cancer Center

Clinical Trials Glenn J. Lesser is currently running

More about Glenn J. Lesser

Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Glenn J. Lesser has experience with

OKN-007
Temozolomide
Retifanlimab
Bevacizumab
Epacadostat
Radiation Therapy

Breakdown of trials Glenn J. Lesser has run

Brain Tumor

Glioblastoma

Brain Cancer

Protoplasmic Astrocytoma

Oligodendroblastoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Glenn J. Lesser specialize in?

Glenn J. Lesser focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved SMO positive patients, or patients who are PTCH1 positive.

Is Glenn J. Lesser currently recruiting for clinical trials?

Yes, Glenn J. Lesser is currently recruiting for 4 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.

Are there any treatments that Glenn J. Lesser has studied deeply?

Yes, Glenn J. Lesser has studied treatments such as OKN-007, Temozolomide, Retifanlimab.

What is the best way to schedule an appointment with Glenn J. Lesser?

Apply for one of the trials that Glenn J. Lesser is conducting.

What is the office address of Glenn J. Lesser?

The office of Glenn J. Lesser is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Glenn J. Lesser is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Glenn J. Lesser

Wake Forest University Health Sciences

Area of expertise

Affiliated Hospitals

Clinical Trials Glenn J. Lesser is currently running

More about Glenn J. Lesser

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Glenn J. Lesser

Wake Forest University Health Sciences

Area of expertise

Affiliated Hospitals

Clinical Trials Glenn J. Lesser is currently running

Multiple Therapies

for Glioblastoma

This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.

Multiple Targeted Therapies

for Meningioma

This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.

More about Glenn J. Lesser

Other Doctors you might be interested in

Frequently asked questions